Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Dionne, A, Dahdah, N, Singh-Grewal, D, Burgner, DP, Newburger, JW, de Ferranti, SD.
Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey..
Int J Cardiol
307:
154 -158
2020
view publication
Liu, M, Lycett, K, Wake, M, He, M, Kerr, JA, Saffery, R, Juonala, M, Olds, T, Dwyer, T, Burgner, DP, et al.
Cardiovascular health and retinal microvascular geometry in Australian 11-12 year-olds..
Microvasc Res
129:
103966
2020
view publication
Dong, Y, Wang, L, Burgner, DP, Miller, JE, Song, Y, Ren, X, Li, Z, Xing, Y, Ma, J, Sawyer, SM, et al.
Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017..
BMJ
369:
m1043
2020
view publication
Wang, J, Liu, M, Sung, V, Lycett, K, Grobler, A, Burgner, D, Wong, TY, Wake, M.
Associations of Retinal Vessel Caliber With Hearing Status in Childhood and Midlife: A Cross-Generational Population-Based Study..
JAMA Otolaryngol Head Neck Surg
146(4)
:
323 -330
2020
view publication